Does XTANDI Cause Dyspnoea? 30 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Dyspnoea have been filed in association with XTANDI. This represents 2.2% of all adverse event reports for XTANDI.
30
Reports of Dyspnoea with XTANDI
2.2%
of all XTANDI reports
2
Deaths
13
Hospitalizations
How Dangerous Is Dyspnoea From XTANDI?
Of the 30 reports, 2 (6.7%) resulted in death, 13 (43.3%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XTANDI. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does XTANDI Cause?
Malignant neoplasm progression (235)
Death (234)
Fatigue (162)
Drug ineffective (158)
Prostatic specific antigen increased (94)
Nausea (69)
Asthenia (62)
Decreased appetite (56)
Dizziness (52)
Diarrhoea (51)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)